Regen Biopharma Stock Analysis
| RGBP Stock | USD 0.20 0.02 9.09% |
Regen BioPharma is overvalued with Real Value of 0.21 and Hype Value of 0.22. The main objective of Regen BioPharma pink sheet analysis is to determine its intrinsic value, which is an estimate of what Regen BioPharma is worth, separate from its market price. There are two main types of Regen BioPharma's stock analysis: fundamental analysis and technical analysis.
The Regen BioPharma pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Regen |
Regen Pink Sheet Analysis Notes
The company had not issued any dividends in recent years. Regen BioPharma had 1:1500 split on the 6th of March 2023. Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California. Regen Biopharma operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for Regen BioPharma is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Regen BioPharma contact David Koos at 619 722 5505 or learn more at https://regenbiopharmainc.com.Regen BioPharma Investment Alerts
| Regen BioPharma is way too risky over 90 days horizon | |
| Regen BioPharma has some characteristics of a very speculative penny stock | |
| Regen BioPharma appears to be risky and price may revert if volatility continues | |
| Regen BioPharma has a very high chance of going through financial distress in the upcoming years | |
| Regen BioPharma currently holds 1.58 M in liabilities with Debt to Equity (D/E) ratio of 1.25, which is about average as compared to similar companies. Regen BioPharma has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Regen BioPharma until it has trouble settling it off, either with new capital or with free cash flow. So, Regen BioPharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Regen BioPharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Regen to invest in growth at high rates of return. When we think about Regen BioPharma's use of debt, we should always consider it together with cash and equity. | |
| Regen BioPharma currently holds about 110.99 K in cash with (606.92 K) of positive cash flow from operations. |
Regen Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.1 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Regen BioPharma's market, we take the total number of its shares issued and multiply it by Regen BioPharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Regen Profitablity
The company has Profit Margin (PM) of 6.09 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of (2.96) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.96.Technical Drivers
As of the 28th of September, Regen BioPharma holds the Semi Deviation of 16.12, coefficient of variation of 2045.74, and Risk Adjusted Performance of 0.049. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Regen BioPharma, as well as the relationship between them.Regen BioPharma Price Movement Analysis
The output start index for this execution was five with a total number of output elements of fifty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Regen BioPharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Regen BioPharma. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Regen BioPharma Outstanding Bonds
Regen BioPharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Regen BioPharma uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Regen bonds can be classified according to their maturity, which is the date when Regen BioPharma has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| REGENERON PHARMACEUTICALS INC Corp BondUS75886FAF45 | View | |
| REGENERON PHARMACEUTICALS INC Corp BondUS75886FAE79 | View | |
| US75884RBA05 Corp BondUS75884RBA05 | View | |
| REGENCY CTRS L Corp BondUS75884RAV50 | View | |
| US75884RAW34 Corp BondUS75884RAW34 | View | |
| REGENCY CTRS L Corp BondUS75884RAU77 | View | |
| US75884RAZ64 Corp BondUS75884RAZ64 | View | |
| REGENCY CTRS L Corp BondUS75884RAX17 | View |
Regen BioPharma Predictive Daily Indicators
Regen BioPharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Regen BioPharma pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 1580.18 | |||
| Daily Balance Of Power | (0.33) | |||
| Rate Of Daily Change | 0.91 | |||
| Day Median Price | 0.19 | |||
| Day Typical Price | 0.19 | |||
| Period Momentum Indicator | (0.02) | |||
| Relative Strength Index | 54.51 |
Regen BioPharma Forecast Models
Regen BioPharma's time-series forecasting models are one of many Regen BioPharma's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Regen BioPharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Regen Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Regen BioPharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Regen shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Regen BioPharma. By using and applying Regen Pink Sheet analysis, traders can create a robust methodology for identifying Regen entry and exit points for their positions.
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California. Regen Biopharma operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Regen BioPharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
| All Next | Launch Module |
Additional Tools for Regen Pink Sheet Analysis
When running Regen BioPharma's price analysis, check to measure Regen BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regen BioPharma is operating at the current time. Most of Regen BioPharma's value examination focuses on studying past and present price action to predict the probability of Regen BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regen BioPharma's price. Additionally, you may evaluate how the addition of Regen BioPharma to your portfolios can decrease your overall portfolio volatility.